ArticleInternational journal of technology assessment in health care2026
Integrating ethical analysis in health technology assessment: opportunities and challenges.
Article in International journal of technology assessment in health care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ethics has been recognized as an integral part of Health Technology Assessment (HTA) since its beginning. However, the integration of ethical analysis in HTA practice has been limited and challenging. Members of the Health Technology Assessment international (HTAi) Interest Group (IG) for Ethical Issues in HTA reflected upon this situation, during a workshop and online meetings, to identify which challenges hinder integration of ethics in HTA and how to move the discipline forward. In this article, we present the results of that discussion, describing different ways that ethical analysis can occupy a more central role in HTA practice. We also describe developments in HTA that create a momentum for reflecting upon such integral role for ethical analysis in HTA: artificial intelligence-based health technologies, changes in the evidence landscape, assessing the environmental impact of health technology, and the new EU regulation on HTA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.